Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Extensive transmission of microbes along the gastrointestinal tract.

Schmidt TSB, Hayward MR, Coelho LP, Li SS, Costea PI, Voigt AY, Wirbel J, Maistrenko OM, Alves RJ, Bergsten E, de Beaufort C, Sobhani I, Heintz-Buschart A, Sunagawa S, Zeller G, Wilmes P, Bork P.

Elife. 2019 Feb 12;8. pii: e42693. doi: 10.7554/eLife.42693. [Epub ahead of print]

2.

Differential hairless mouse strain-specific susceptibility to skin cancer and sunburn.

Voigt AY, Michaud M, Tsai KY, Oh J, Sundberg JP.

J Invest Dermatol. 2019 Feb 8. pii: S0022-202X(19)30109-5. doi: 10.1016/j.jid.2019.01.028. [Epub ahead of print] No abstract available.

PMID:
30742806
3.

Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.

Tastan C, Karhan E, Zhou W, Fleming E, Voigt AY, Yao X, Wang L, Horne M, Placek L, Kozhaya L, Oh J, Unutmaz D.

Mucosal Immunol. 2018 Nov;11(6):1591-1605. doi: 10.1038/s41385-018-0072-x. Epub 2018 Aug 16.

4.

Metagenomic analysis of gut microbial communities from a Central Asian population.

Kushugulova A, Forslund SK, Costea PI, Kozhakhmetov S, Khassenbekova Z, Urazova M, Nurgozhin T, Zhumadilov Z, Benberin V, Driessen M, Hercog R, Voigt AY, Benes V, Kandels-Lewis S, Sunagawa S, Letunic I, Bork P.

BMJ Open. 2018 Jul 28;8(7):e021682. doi: 10.1136/bmjopen-2018-021682.

5.

Corrigendum: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Costea PI, Kultima JR, Li J, Jørgensen T, Levenez F, Dore J; MetaHIT consortium, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O.

Nature. 2017 May 3;545(7652):116. doi: 10.1038/nature22318. No abstract available.

PMID:
28470190
6.

[Microbial Biomarkers for Early Cancer Detection].

Voigt AY, Zeller G, Bork P.

Dtsch Med Wochenschr. 2017 Feb;142(4):267-274. doi: 10.1055/s-0042-110193. Epub 2017 Feb 24. Review. German.

PMID:
28235227
7.

Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing.

Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, Goedert JJ, Shi J, Bork P, Sinha R.

PLoS One. 2016 May 12;11(5):e0155362. doi: 10.1371/journal.pone.0155362. eCollection 2016.

8.

MOCAT2: a metagenomic assembly, annotation and profiling framework.

Kultima JR, Coelho LP, Forslund K, Huerta-Cepas J, Li SS, Driessen M, Voigt AY, Zeller G, Sunagawa S, Bork P.

Bioinformatics. 2016 Aug 15;32(16):2520-3. doi: 10.1093/bioinformatics/btw183. Epub 2016 Apr 8.

9.

Durable coexistence of donor and recipient strains after fecal microbiota transplantation.

Li SS, Zhu A, Benes V, Costea PI, Hercog R, Hildebrand F, Huerta-Cepas J, Nieuwdorp M, Salojärvi J, Voigt AY, Zeller G, Sunagawa S, de Vos WM, Bork P.

Science. 2016 Apr 29;352(6285):586-9. doi: 10.1126/science.aad8852.

10.

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Costea PI, Kultima JR, Li J, Jørgensen T, Levenez F, Dore J; MetaHIT consortium, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O.

Nature. 2015 Dec 10;528(7581):262-266. doi: 10.1038/nature15766. Epub 2015 Dec 2. Erratum in: Nature. 2017 May 3;545(7652):116.

11.

Temporal and technical variability of human gut metagenomes.

Voigt AY, Costea PI, Kultima JR, Li SS, Zeller G, Sunagawa S, Bork P.

Genome Biol. 2015 Apr 8;16:73. doi: 10.1186/s13059-015-0639-8.

12.

Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.

Surmann EM, Voigt AY, Michel S, Bauer K, Reuschenbach M, Ferrone S, von Knebel Doeberitz M, Kloor M.

Cancer Immunol Immunother. 2015 Mar;64(3):357-66. doi: 10.1007/s00262-014-1638-4. Epub 2014 Dec 2.

PMID:
25445815
13.

Potential of fecal microbiota for early-stage detection of colorectal cancer.

Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P.

Mol Syst Biol. 2014 Nov 28;10:766. doi: 10.15252/msb.20145645.

14.

LotuS: an efficient and user-friendly OTU processing pipeline.

Hildebrand F, Tadeo R, Voigt AY, Bork P, Raes J.

Microbiome. 2014 Sep 30;2(1):30. doi: 10.1186/2049-2618-2-30.

15.

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Kloor M, Huth C, Voigt AY, Benner A, Schirmacher P, von Knebel Doeberitz M, Bläker H.

Lancet Oncol. 2012 Jun;13(6):598-606. doi: 10.1016/S1470-2045(12)70109-2. Epub 2012 May 1.

PMID:
22552011
16.

The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.

Huth C, Kloor M, Voigt AY, Bozukova G, Evers C, Gaspar H, Tariverdian M, Schirmacher P, von Knebel Doeberitz M, Bläker H.

Mod Pathol. 2012 Jun;25(6):911-6. doi: 10.1038/modpathol.2012.30. Epub 2012 Mar 2.

17.

Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.

Kloor M, Voigt AY, Schackert HK, Schirmacher P, von Knebel Doeberitz M, Bläker H.

J Clin Oncol. 2011 Jan 10;29(2):223-7. doi: 10.1200/JCO.2010.32.0820. Epub 2010 Nov 29.

PMID:
21115857

Supplemental Content

Loading ...
Support Center